PureTech Scientific’s $137 Million Acquisition of The Chemours Company’s Glycolic Acid Business

McDermott Will & Emery represented Iron Path Capital, while Spilman Thomas & Battle represented Chemours in the transaction.PureTech Scientific announced the acquisition of The Chemours Company’s Glycolic…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now